Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 356-362

  Chapp Jumbo, Emmanuel ^a   Edeoga, Chimaroke ^a   Wan, Jim ^a   Dagogo Jack, Samuel ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AFRICAN AMERICAN; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE; BLOOD CELL COUNT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAUCASIAN; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROGENY; WAIST CIRCUMFERENCE;

EID: 84861078141     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11245.OR     Document Type: Article

References (39)

1. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science. 1978; 200:21-27.
2. The effect of intensive treatment of diabetes on the devel-opment and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329:977-986.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group (Erratum in: Lancet. 1999;354:602).
4. Lancet. 1998;352:837-853.
5. American Diabetes Association. Diagnosis and classifica-tion of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1): S62-S69.
6. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011; 17(Suppl 2):1-53.
7. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-1334.
8. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: Pathophysiology and implications for prevention and man-agement. J Natl Med Assoc. 2003;95:774,779-789.
9. Kirk JK, D'Agostino RB Jr, Bell RA, et al. Disparities in HbA1c levels between African-American and non-His-panic white adults with diabetes: A meta-analysis. Diabetes Care. 2006;29:2130-2136.
10. Davidson MB, Schriger DL. Effect of age and race/eth-nicity on HbA1c levels in some people without known dia-betes mellitus: Implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87:415-421.
11. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetic Care. 2007;30:2453-2457.
12. Herman WH, Dungan KM, Wolffenbuttel BH, et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:1689-1694.
13. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152:770-777.
14. Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care. 2009;32:828-833.
15. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care. 2010;33:2184-2189.
16. Dagogo-Jack S, Edeoga C, Nyenwe E, Chapp-Jumbo E, Wan J. Pathobiology of prediabetes in a biracial cohort (POP-ABC): Design and methods. Ethn Dis. 2011;21:33-39.
17. Levy JC, Matthews DR, Hermans MP. Correct homeo-stasis model assessment (HOMA) evaluation uses the com-puter program. Diabetes Care. 1998;21:2191-2192.
18. Bleyer AJ, Hire D, Russell GB, et al. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet Med. 2009;26:128-133.
19. Kamps JL, Hempe JM, Chalew SA. Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care. 2010;33:1025-1027.
20. Kirk JK, Passmore LV, Bell RA, et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care. 2008;31:240-246.
21. Christensen DL, Witte DR, Kaduka L, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580-582.
22. Dagogo-Jack S. Pitfalls in the use of HbA1(c) as a diag-nostic test: The ethnic conundrum. Nat Rev Endocrinol. 2010;6:589-593.
23. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1diabetes: Evidence from healthy and diabetic twins. Diabetes. 2001;50:2858-2863.
24. Bonnefond A, Vaxillaire M, Labrune Y, et al. A genetic variant in HK1 is associated with proanemic state and A1C but not other glycemic control-related traits. Diabetes. 2009;58:2687-2697.
25. Soranzo N, Sanna S, Wheeler E, et al. Common variants at 10 genomic loci influence hemoglobin A1(c) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59: 3229-3239.
26. Khera PK, Joiner CH, Carruthers A, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes. 2008;57:2445-2452.
27. Hempe JM, Gomez R, McCarter RJ, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 dia-betes: A challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313-320.
28. Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem. 1999;36:451-459.
29. Cohen RM. Editorial: A1C: Does one size fit all? Diabetes Care. 2007;30:2756-2758.
30. Delpierre G, Collard F, Fortpied J, Van Schaftingen E. Fructosamine 3-kinase is involved in an intracellular degly-cation pathway in human erythrocytes. Biochem J. 2002; 365: 801-808.
31. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: A cross-sectional analysis of community-based data. Ann Intern Med. 2011;154:303-309.
32. Maruthur NM, Kao WH, Clark JM, et al. Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes. 2011;60:2434-2438.
33. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473-1478.
34. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20: 1183-1197.
35. World Health Organization, Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999: 1-59.
36. Genuth S, Alberti KG, Bennett P, et al; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
37. Saaddine JB, Fagot-Campagna A, Rolka D, et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care. 2002;25:1326-1330.
38. Centers for Disease Control and Prevention. 2007 National Diabetes Fact Sheet. http://www.cdc.gov/diabe-tes/pubs/factsheet07.htm. Accessed June 18, 2011.
39. Vable AM, Drum ML, Tang H, Chin MH, Lindau ST, Huang ES. Implications of the new definition of diabetes for health disparities. J Natl Med Assoc. 2011;103:219-223.